Announcements Trials
Browse Landscape

Status

Unknown 2Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Hematologic Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2

Interventions

Blood Specimen Collection 87Surveys and Questionnaires 86Surgical Procedures, Operative 45Drug Therapy 33Radiotherapy 28Biopsy 26Neoadjuvant Therapy 24Amplified Fragment Length Polymorphism Analysis 24Immunohistochemistry 22Gene Expression Profiling 21Bevacizumab 19Magnetic Resonance Spectroscopy 17Immunotherapy 17Data Collection 17Ultrasonography 16Positron Emission Tomography Computed Tomography 16Liquid Biopsy 16pembrolizumab 15Observation 15Nivolumab 15Watchful Waiting 14Radiosurgery 14Microarray Analysis 14Magnetic Resonance Imaging 14Interviews as Topic 14Immune Checkpoint Inhibitors 14Colonoscopy 13Capecitabine 13Polymerase Chain Reaction 12Paclitaxel 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Observational × Voriconazole × Clear all
NCT04743544 2021-02-08

Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy

Dokuz Eylul University

Unknown
62 enrolled
Other hematologic neoplasm

Hematologic Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT04547335 2020-09-16

The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole

Dokuz Eylul University

Unknown
34 enrolled
Other hematologic neoplasm

Hematologic Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡